Prophylactic/therapeutic agent for cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090155241A1
SERIAL NO

11988995

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound or its salt that inhibits the activity of a protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1; a compound or its salt that inhibits the expression of a gene for the protein; an antisense polynucleotide comprising a nucleotide sequence complementary or substantially complementary to the nucleotide sequence of a polynucleotide encoding the protein or a partial peptide thereof or a part of the nucleotide sequence; an antibody against the protein; etc. are useful as preventive/therapeutic agents for cancer, apoptosis promoters for cancer cells, or the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 541-8645
JAPANESE FOUNDATION FOR CANCER RESEARCH8-31 ARIAKE 3-CHOME KOTO-KU TOKYO 135-8550

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mashima, Tetsuo Tokyo , JP 3 4
Tsuruo, Takashi Tokyo , JP 17 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation